FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
Main Authors: | , , , , , , , , , |
---|---|
Formato: | Conference item |
Idioma: | English |
Publicado: |
BMJ Publishing Group
2021
|
Main Authors: | , , , , , , , , , |
---|---|
Formato: | Conference item |
Idioma: | English |
Publicado: |
BMJ Publishing Group
2021
|